226 related articles for article (PubMed ID: 12652960)
1. [Significance of damage index in predicting systemic lupus erythematosus outcome].
Tarasova IA; Ivanova MM; Zhorniak AP; Nasonova VA
Ter Arkh; 2003; 75(1):59-62. PubMed ID: 12652960
[TBL] [Abstract][Full Text] [Related]
2. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
3. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
Nossent JC
J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
[TBL] [Abstract][Full Text] [Related]
5. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
6. Item weightings for the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Disease Damage Index using Rasch analysis do not lead to an important improvement.
Brunner HI; Feldman BM; Urowitz MB; Gladman DD
J Rheumatol; 2003 Feb; 30(2):292-7. PubMed ID: 12563683
[TBL] [Abstract][Full Text] [Related]
7. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
Mok CC; Ho LY; Cheung MY; Yu KL; To CH
Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
[TBL] [Abstract][Full Text] [Related]
8. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
10. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.
Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Fortin P; Ginzler E; Gordon C; Hanly JG; Isenberg DA; Petri M; Nived O; Snaith M; Sturfelt G
J Rheumatol; 2000 Feb; 27(2):373-6. PubMed ID: 10685799
[TBL] [Abstract][Full Text] [Related]
11. A comparison of prospective and retrospective evaluations of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus.
Bernatsky S; Clarke A; Abrahamowicz M; Neville C; Karp I; Pineau CA
J Rheumatol; 2005 May; 32(5):820-3. PubMed ID: 15868615
[TBL] [Abstract][Full Text] [Related]
12. Recurrent major infections in juvenile-onset systemic lupus erythematosus--a close link with long-term disease damage.
Lee PP; Lee TL; Ho MH; Wong WH; Lau YL
Rheumatology (Oxford); 2007 Aug; 46(8):1290-6. PubMed ID: 17522097
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
14. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
15. Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the Rey Auditory Verbal Learning Test.
Paran D; Litinsky I; Shapira-Lichter I; Navon S; Hendler T; Caspi D; Vakil E
Ann Rheum Dis; 2009 Jun; 68(6):812-6. PubMed ID: 18593761
[TBL] [Abstract][Full Text] [Related]
16. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
17. Socioeconomic status and health in women with systemic lupus erythematosus.
Lotstein DS; Ward MM; Bush TM; Lambert RE; van Vollenhoven R; Neuwelt CM
J Rheumatol; 1998 Sep; 25(9):1720-9. PubMed ID: 9733452
[TBL] [Abstract][Full Text] [Related]
18. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
19. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
Mikdashi J; Handwerger B
Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
[TBL] [Abstract][Full Text] [Related]
20. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
Brunner HI; Silverman ED; Bombardier C; Feldman BM
Arthritis Rheum; 2003 Jun; 49(3):335-41. PubMed ID: 12794788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
